ConductScience.org, home

Paper38660941

Managing the new wave of weight loss medication in general practice: A qualitative study.

Andreassen P and 3 others. Clin Obes, 2024. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Managing the new wave of weight loss medication in general practice: A qualitative study. Papers, record 38660941. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38660941

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Managing the new wave of weight loss medication in general practice: A qualitative study.
PubMed
Journal
Clin Obes
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
4.57, provisional
iCite
Revised in PubMed
2025-05-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Andreassen PPernille
2Jensen SDSissel Due
3Bruun JMJens M
4Sandbæk AAnnelli

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
General PracticeMajor topic
Qualitative ResearchMajor topic
Anti-Obesity AgentsMajor topic
Humans
Denmark
Female
Male
Weight Loss
Middle Aged
Adult
Obesity
Trust
General Practitioners
Attitude of Health Personnel

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Novo Nordisk FoundationPubMed

Source PubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in40419330Correction to "Managing the New Wave of Weight Loss Medication in General Practice: A Qualitative Study".https://conductscience.org/library/papers/40419330

Source PubMed

Download CSV of comments and corrections

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
42859781Hope, hype, and high costs: Navigating glucagon-like Peptide-1 based therapy initiation among young adults.Obes Pillars2026https://conductscience.org/library/papers/42859781PubMed
42630863Attitudes Toward Injectable GLP-1 Drugs for Obesity Treatment: A Qualitative Interview Study With Healthcare Professionals.Obes Sci Pract2026https://conductscience.org/library/papers/42630863PubMed
42608457GLP-1 receptor agonists and the emergence of treatment-related stigma: a call for conceptual clarity.Int J Obes (Lond)2026https://conductscience.org/library/papers/42608457PubMed
42443134Treatment Patterns and Experienced Effects of Semaglutide for Weight Management Among Adult Users in Denmark: A Community Pharmacy-Based Cross-Sectional Survey.Diabetes Obes Metab2026https://conductscience.org/library/papers/42443134PubMed
42181798Social Perceptions of Weight Loss With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Black and White Women With Obesity.Stigma Health2026https://conductscience.org/library/papers/42181798PubMed
42131535Drugs, diet, or surgery? How treatment type and willpower shape responsibility for weight loss and judgments of the physician and treatment.Front Psychol2026https://conductscience.org/library/papers/42131535PubMed
42085357
Weight Management and Healthcare Utilization among Adults with Overweight and Obesity in Germany: A Representative Survey of General Practitioner Consultations and Digital and Pharmacological Treatment Options.
Obes Facts2026https://conductscience.org/library/papers/42085357PubMed
41838446A qualitative study exploring experiences about using semaglutide for weight loss in a rural setting in Denmark - 'she is probably on the meds'.Scand J Prim Health Care2026https://conductscience.org/library/papers/41838446PubMed
41527217Changes in how people living with obesity perceive weight-related discussions with their healthcare professional: Results from the cross-sectional online ACTION-DK 2022 and 2024 studies.Diabetes Obes Metab2026https://conductscience.org/library/papers/41527217PubMed
41452858Beyond the prescription: Global observations on the social implications of GLP-1 receptor agonists for weight loss.PLOS Glob Public Health2025https://conductscience.org/library/papers/41452858PubMed
41299124Primary Care Providers Perspectives of GLP-1 Receptor Agonists to Manage Recurrent Weight Gain after Metabolic Bariatric Surgery - a Qualitative Study.Obes Surg2026https://conductscience.org/library/papers/41299124PubMed
40903862Treat to target in weight management with semaglutide: Real-world evidence from an eHealth clinic.Diabetes Obes Metab2025https://conductscience.org/library/papers/40903862PubMed
40628416GPs' perspectives on GLP-1RAs for obesity management: a qualitative study in England.Br J Gen Pract2025https://conductscience.org/library/papers/40628416PubMed
40521912'This Is My Decision': A Qualitative Study of Individuals' Perspectives on Use of Semaglutide for Weight Loss.Basic Clin Pharmacol Toxicol2025https://conductscience.org/library/papers/40521912PubMed
40306953GLP-1 Receptor Agonists for Treatment of Pediatric Obesity: Behavioral Health Considerations.Child Obes2025https://conductscience.org/library/papers/40306953PubMed
40227008What Are the Experiences, Views and Perceptions of Patients, Carers and Clinicians of Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs)? A Scoping Review.Health Expect2025https://conductscience.org/library/papers/40227008PubMed
39907856The Impact of Novel Medications for Obesity on Weight Stigma and Societal Attitudes: A Narrative Review.Curr Obes Rep2025https://conductscience.org/library/papers/39907856PubMed
39905646Survey among adult users of semaglutide for weight loss in Denmark: User characteristics, treatment expectations and experienced effects.Diabetes Obes Metab2025https://conductscience.org/library/papers/39905646PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38660941

GET https://conductscience.org/api/papers/v1/38660941/authors